Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Working Paper<<
January 30, 2026
“B” is for “big gifts”: Characterizing donor-recipient charitable relationships using Form 990 Schedule B. SSRN Working Paper.
>> New Publication <<
August 18, 2025
Conflicts of interest in federal vaccine advisory committees. [PDF] JAMA 2025. Online ahead of print.
>> New Publication <<
July 31, 2025
Impact of the MISSION Act on quality and outcomes of major cardiovascular procedures among veterans. JAMA 2025. Online ahead of print.
STAT News
March 9, 2026
As controversial decisions mount, FDA shuns public advisory meetings [PDF]
by Lizzy Lawrence
Regulatory Focus
February 17, 2026
Experts argue recent FDA expert panels may violate FACA requirements
by Jeff Craven
PharmaVoice
January 29, 2026
Politicization runs deeper than ever at FDA, risking long-term impacts
by Michael Gibney